BioSpace News Archive

Drug Development

Ascletis Embarks on Mid-stage Study of Potentially Functional Cure for HIV

Ascletis has commenced its Phase II trial in China for its candidate drug ASC22 alongside anti-retroviral therapy for the functional cure and immune restoration of HIV-1 infection.

June 28, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Roivant Reduces Pipeline by Several Programs Across Vants

Roivant Sciences announced it has discontinued development of several assets following a pipeline reprioritization.

June 28, 2022
·
3 min read
·
Alex Keown
Business

Beyond Increments: Black Perspectives on Representation in the Life Sciences

BioSpace spoke with several Black individuals working within the life sciences to get their thoughts on the current representative disconnect and what they believe can be done to fix it.

June 28, 2022
·
10 min read
·
Heather McKenzie
Business

Biogen Community Lab 2.0 Reveals Wonders of Science to Thousands of Students

Biogen’s Chirfi Guindo discusses the launch of the company’s next-generation approach to teaching STEM to even more students, leading to potential careers in the field.

June 28, 2022
·
4 min read
·
Alex Keown
Business

Novartis Reveals Restructure will Cost up to 8,000 Jobs

Swiss biopharma giant Novartis plans to cut up to 8,000 jobs in hopes of saving at least $1 billion by 2024.

June 28, 2022
·
3 min read
·
Mark Terry
Esthetic Lasers and Energy Devices Market Insights by Size, Status and Forecast 2025

Wilmington, Delaware, United States: In the past few years, the cosmetic industry has found new bioactive and high potency ingredients, which offer noticeable skin benefits to consumers.

June 28, 2022
·
7 min read
Diagnostic ENT Devices to Add on More Revenues to ENT Devices Swelling from Over 1/4th of the Total Revenue, States Fact.MR

Extensive development of the new age technology has prompted ENT Device manufacturers to launch highly robust, durable and smart components, aimed at increasing life supports, providing renewed growth opportunities for ENT device industry, comments a Fact.MR analyst.

June 28, 2022
·
6 min read
Increasing Healthcare Expenditure to Drive Sales of Reprocessed Medical Devices at 14.9% CAGR through 2028: Fact.MR Survey

Fact.MR – A Market Research and Competitive Intelligence Provider: The reprocessed medical devices market stood at a valuation of US$ 2.05 Bn in 2020, and is projected to surge to US$ 5.9 Bn by the end of 2028.

June 28, 2022
·
7 min read
Obvious Preference for No Sting Barrier Sprays Due to Ease of Application and Uniformity, States Fact.MR

Fact.MR – A Market Research and Competitive Intelligence Provider: The global no sting barrier market is estimated to reach a valuation of US$ 707.5 million by 2032 expanding at an impressive CAGR of 7.2% during the forecast years.

June 28, 2022
·
6 min read
Drug Discovery Technologies Market Analysis of the Competitive Landscape, with a Forecast for 2031

Wilmington, Delaware, United States: Drug discovery is the process of discovering new medications for different purposes.

June 28, 2022
·
6 min read